4.8 Article

Regulation of the androgen receptor by SET9-mediated methylation

Journal

NUCLEIC ACIDS RESEARCH
Volume 39, Issue 4, Pages 1266-1279

Publisher

OXFORD UNIV PRESS
DOI: 10.1093/nar/gkq861

Keywords

-

Funding

  1. Cancer Research UK
  2. Association for International Cancer Research
  3. Cancer Research UK Association for International Cancer Research
  4. MRC [G0601123, G0900871] Funding Source: UKRI
  5. Academy of Medical Sciences (AMS) [AMS-SGCL4-McCracken] Funding Source: researchfish
  6. Medical Research Council [G0900871, G0601123] Funding Source: researchfish

Ask authors/readers for more resources

The androgen receptor (AR) is a member of the nuclear hormone receptor family of transcription factors that plays a critical role in regulating expression of genes involved in prostate development and transformation. Upon hormone binding, the AR associates with numerous co-regulator proteins that regulate the activation status of target genes via flux to the post-translational modification status of histones and the receptor. Here we show that the AR interacts with and is directly methylated by the histone methyltransferase enzyme SET9. Methylation of the AR on lysine 632 is necessary for enhancing transcriptional activity of the receptor by facilitating both inter-domain communication between the N- and C-termini and recruitment to androgen-target genes. We also show that SET9 is pro-proliferative and anti-apoptotic in prostate cancer cells and demonstrates up-regulated nuclear expression in prostate cancer tissue. In all, our date indicate a new mechanism of AR regulation that may be therapeutically exploitable for prostate cancer treatment.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available